COVID-19: Total Coronavirus Cases Rose to 17,50,724 in India

India’s total coronavirus cases rose to 17,50,724 today, an record single-day increase of 54,736 cases, according to the Union Health Ministry data.

COVID-19: Total Coronavirus Cases Rose to 17,50,724 in India

India’s total coronavirus cases rose to 17,50,724 today, an record single-day increase of 54,736 cases, according to the Union Health Ministry data. The recoveries surged to 11,45,629, including 51,255 in past 24 hours. The death toll due to COVID-19 climbed to 37,364 with 853 people succumbing to the disease in a 24-hour span.

At present, there are 5,67,730 active cases in the country. The recovery rate stood at 64.53% while the fatality rate at 2.15%.

ALSO READ: UP Govt Allows To Open Rakhi & Sweets Shops On Sunday Due to Raksha Bandhan

This is the fourth consecutive day that COVID-19 cases have increased by more than 50,000.

According to the ICMR, a cumulative total of 1,98,21,831 samples have been tested up to August 1 with 4,63,172 being tested on Saturday.

Six months after the World Health Organization declared a global emergency, the novel coronavirus, the total number of coronavirus cases globally has crossed 1.77 crore while 6.84 lakh have died of the infection.

ALSO READ: Former SP leader and RS MP Amar Singh dies at 64

US:

The US, the worst affected country, reported over 1,000 deaths for a fifth consecutive day.

“WHO continues to assess the global risk level of COVID-19 to be very high,” it said in its latest statement.

The pandemic has spurred a race for a coronavirus vaccine with many candidates in late stage trial.

ALSO READ: UP Cabinet minister Kamal Rani Varun Dies of COVID-19 at 62

In India, two indigenously developed vaccine candidates are undergoing trials. Meanwhile, Serum Institute of India (SII), the world’s biggest vaccine maker, has signed an agreement to manufacture a potential coronavirus vaccine being developed by Jenner Institute of Oxford University in collaboration with British-Swedish pharma company AstraZeneca.

Stay tuned with the newstrack to get fastest updates.

Click @englishnewstrack to follow us on Facebook.

and @newstrackmedia to follow on Twitter.